The Role of Radioiodine Therapy in Differentiated Thyroid Cancer Arising from Struma Ovarii: A Systematic Review
Pietro Bellini, Francesco Dondi, Valentina Zilioli, Elisa Gatta, Maria Cavadini, Carlo Cappelli, Gian Luca Viganò, Francesco Bertagna · 2024
Read The Role of Radioiodine Therapy in Differentiated Thyroid Cancer Arising from Struma Ovarii: A Systematic Review by Pietro Bellini, Francesco Dondi, Valentina Zilioli, Elisa Gatta, Maria Cavadini, Carlo Cappelli, Gian Luca Viganò, Francesco Bertagna (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11680078.txt.
Description
Pietro Bellini and co-authors review whether radioactive iodine helps when thyroid cancer grows inside an ovarian tumor, in a 2024 paper. Struma ovarii is an ovarian growth made largely of thyroid tissue. Rarely, that tissue turns cancerous. Treatment then borrows from thyroid cancer care, but the rules are murky. Surgery alone may or may not suffice.
The team searched major databases for treated cases. Eleven studies met their quality checks. All were retrospective, reflecting how rare the condition is. Radioiodine's role was weighed against recurrence and survival patterns. The synthesis helps tumor boards advise patients with few precedents. It also shows where a registry could settle open questions. Rare cancer care advances through exactly such pooling.
Catalog record
| CREATOR | Pietro Bellini, Francesco Dondi, Valentina Zilioli, Elisa Gatta, Maria Cavadini, Carlo Cappelli, Gian Luca Viganò, Francesco Bertagna |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |